Six-minute walk test as a prognostic tool in stable coronary heart disease: data from the heart and soul study
- PMID: 22710902
- PMCID: PMC3420342
- DOI: 10.1001/archinternmed.2012.2198
Six-minute walk test as a prognostic tool in stable coronary heart disease: data from the heart and soul study
Abstract
Background: The prognostic value of the 6-minute walk test (6MWT) in patients with stable coronary heart disease is unknown. We sought to determine whether the 6MWT predicted cardiovascular events in ambulatory patients with coronary heart disease.
Methods: We measured 6MWT distance and treadmill exercise capacity in 556 outpatients with stable coronary heart disease from September 11, 2000, through December 20, 2002. Participants were followed up for a median of 8.0 years for cardiovascular events (heart failure, myocardial infarction, and death).
Results: Cardiovascular events occurred in 218 of 556 participants (39.2%). Patients in the lowest quartile of 6MWT distance (87-419 m) had 4 times the rate of events as those in the highest quartile (544-837 m) (unadjusted hazard ratio, 4.29; 95% CI, 2.83-6.53; P < .001). Each SD decrease in 6MWT distance (104 m) was associated with a 55% higher rate of cardiovascular events (age-adjusted hazard ratio, 1.55; 95% CI, 1.35-1.78). After adjustment for traditional risk factors and cardiac disease severity measures (ejection fraction, inducible ischemia, diastolic dysfunction, amino-terminal portion of the prohormone of brain-type natriuretic peptide, and C-reactive protein), each SD decrease in 6MWT was associated with a 30% higher rate of cardiovascular events (hazard ratio, 1.30; 95% CI, 1.10-1.53). When added to traditional risk factors, the 6MWT resulted in category-free net reclassification improvement of 39% (95% CI, 19%-60%). The discriminative ability of the 6MWT was similar to that of treadmill exercise capacity for predicting cardiovascular events (C statistics both 0.72; P = .29).
Conclusions: Distance walked on the 6MWT predicted cardiovascular events in patients with stable coronary heart disease. The addition of a simple 6MWT to traditional risk factors improved risk prediction and was comparable with treadmill exercise capacity.
Figures
Comment in
-
Time for a 6-minute walk?Arch Intern Med. 2012 Jul 23;172(14):1102-3. doi: 10.1001/archinternmed.2012.2530. Arch Intern Med. 2012. PMID: 22710968 No abstract available.
-
Coronary artery disease: the 6-min walk test is useful for assessing prognosis in stable, ambulatory patients.Nat Rev Cardiol. 2012 Jul 10;9(8):432. doi: 10.1038/nrcardio.2012.98. Nat Rev Cardiol. 2012. PMID: 22776984 No abstract available.
-
Moderate exercise for improvement in 6-minute walk test performance in stable coronary heart disease.JAMA Intern Med. 2013 Jan 28;173(2):168-9. doi: 10.1001/2013.jamainternmed.1077. JAMA Intern Med. 2013. PMID: 23358842 No abstract available.
-
Moderate exercise for improvement in 6-minute walk test performance in stable coronary heart disease--reply.JAMA Intern Med. 2013 Jan 28;173(2):169. doi: 10.1001/jamainternmed.2013.1710. JAMA Intern Med. 2013. PMID: 23358843 No abstract available.
Similar articles
-
High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study.JAMA Intern Med. 2013 May 13;173(9):763-9. doi: 10.1001/jamainternmed.2013.116. JAMA Intern Med. 2013. PMID: 23568589 Free PMC article.
-
Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study.Eur J Heart Fail. 2019 Feb;21(2):218-226. doi: 10.1002/ejhf.1380. Epub 2019 Jan 1. Eur J Heart Fail. 2019. PMID: 30600578
-
Left-ventricular power-to-mass ratio at peak exercise predicts mortality, heart failure, and cardiovascular events in patients with stable coronary artery disease: data from the Heart and Soul Study.Cardiology. 2009;114(3):226-34. doi: 10.1159/000231991. Epub 2009 Aug 6. Cardiology. 2009. PMID: 19672059 Free PMC article.
-
Systematic Review of the Use of the 6-Minute Walk Test in Measuring and Improving Prognosis in Patients With Ischemic Heart Disease.CJC Open. 2023 Aug 13;5(11):816-825. doi: 10.1016/j.cjco.2023.08.003. eCollection 2023 Nov. CJC Open. 2023. PMID: 38020329 Free PMC article. Review.
-
A review of the six-minute walk test: its implication as a self-administered assessment tool.Eur J Cardiovasc Nurs. 2009 Mar;8(1):2-8. doi: 10.1016/j.ejcnurse.2008.07.001. Epub 2008 Aug 9. Eur J Cardiovasc Nurs. 2009. PMID: 18694656 Review.
Cited by
-
Association between fingertip-measured advanced glycation end products and cardiovascular events in outpatients with cardiovascular disease.Cardiovasc Diabetol. 2023 Aug 17;22(1):213. doi: 10.1186/s12933-023-01953-x. Cardiovasc Diabetol. 2023. PMID: 37592261 Free PMC article.
-
Accuracy of the 6-Minute Walk Test for Assessing Functional Capacity in Patients With Heart Failure With Preserved Ejection Fraction and Other Chronic Cardiac Pathologies: Results of the ExIC-FEp Trial and a Meta-Analysis.Sports Med Open. 2024 Jun 18;10(1):74. doi: 10.1186/s40798-024-00740-6. Sports Med Open. 2024. PMID: 38886304 Free PMC article.
-
EECP improves markers of functional capacity regardless of underlying ranolazine therapy.Am J Cardiovasc Dis. 2020 Dec 15;10(5):593-601. eCollection 2020. Am J Cardiovasc Dis. 2020. PMID: 33489463 Free PMC article.
-
SMARTphone-based, early cardiac REHABilitation in patients with acute coronary syndromes [SMART-REHAB Trial]: a randomized controlled trial protocol.BMC Cardiovasc Disord. 2016 Sep 5;16(1):170. doi: 10.1186/s12872-016-0356-6. BMC Cardiovasc Disord. 2016. PMID: 27596569 Free PMC article. Clinical Trial.
-
L-Arginine Enhances the Effects of Cardiac Rehabilitation on Physical Performance: New Insights for Managing Cardiovascular Patients During the COVID-19 Pandemic.J Pharmacol Exp Ther. 2022 Jun;381(3):197-203. doi: 10.1124/jpet.122.001149. Epub 2022 Mar 26. J Pharmacol Exp Ther. 2022. PMID: 35339987 Free PMC article.
References
-
- D'Agostino RB, Russell MW, Huse DM, et al. Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J. 2000;139(2 Pt 1):272–281. - PubMed
-
- Vittinghoff E, Shlipak MG, Varosy PD, et al. Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study. Ann Intern Med. 2003;138(2):81–89. - PubMed
-
- Vanhees L, Fagard R, Thijs L, Staessen J, Amery A. Prognostic significance of peak exercise capacity in patients with coronary artery disease. J Am Coll Cardiol. 1994;23(2):358–363. - PubMed
-
- Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793–801. - PubMed